Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | BLM | P54132 | 1/20 | 0.70 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.70 |
| ▸ | PDE3B | Q13370 | 16/20 | 0.64 |
| ▸ | PDE3A | Q14432 | 16/20 | 0.64 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | PDE4A | P27815 | 2/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.47 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Siguazodan SCHEMBL6558367 | 1.00 | KDM4E (0.70) | KDM4EALDH1A1CYP1A2CYP3A4ALOX15 | |
| SCHEMBL10652569 | 0.88 | KDM4E (0.66) | KDM4EALDH1A1CYP1A2CYP3A4ALOX15 | |
| SCHEMBL10762684 | 0.88 | KDM4E (0.66) | KDM4EALDH1A1CYP1A2CYP3A4ALOX15 | |
| SCHEMBL10653471 | 0.88 | KDM4E (0.66) | KDM4EALDH1A1CYP1A2CYP3A4ALOX15 | |
| SCHEMBL10651830 | 0.87 | KDM4E (0.67) | KDM4EALDH1A1CYP1A2CYP3A4ALOX15 | |
| SCHEMBL10765447 | 0.86 | KDM4E (0.64) | KDM4EALDH1A1CYP1A2CYP3A4ALOX15 | |
| SCHEMBL10764400 | 0.86 | KDM4E (0.64) | KDM4EALDH1A1CYP1A2CYP3A4ALOX15 | |
| SCHEMBL10618267 | 0.86 | KDM4E (0.76) | KDM4EALDH1A1CYP1A2CYP3A4ALOX15 | |
| SCHEMBL10764489 | 0.86 | KDM4E (0.63) | KDM4EALDH1A1CYP1A2CYP3A4ALOX15 | |
| SCHEMBL10652516 | 0.85 | KDM4E (0.62) | KDM4EALDH1A1CYP1A2CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1176960-B1 | SYNERGISTIC COMBINATION COMPRISING ROFLUMILAST AND A PDE-3 INHIBITOR | ALTANA PHARMA AG (DE) | 2004-09-29 | — | — | EP | claimed |
| EP-0150937-B1 | DIHYDROPYRIDAZINONES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1988-09-14 | — | — | EP | claimed |
| EP-0150937-A2 | Dihydropyridazinones | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1985-08-07 | — | — | EP | claimed |
| WO-1985003076-A1 | DIHYDROPYRIDAZINONES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1985-07-18 | — | — | WO | claimed |
| JP-1113317-A | — | — | None | — | — | JP | disclosed |
| EP-3334404-A1 | COMPOSITIONS AND METHODS FOR CANCER EXPRESSING PDE3A OR SLFN12 | The Broad Institute, Inc. (US) | 2018-06-20 | — | — | EP | disclosed |
| WO-2017027854-A1 | COMPOSITIONS AND METHODS FOR CANCER EXPRESSING PDE3A OR SLFN12 | THE BROAD INSTITUTE, INC. (US) | 2017-02-16 | — | — | WO | disclosed |
| EP-0946183-B1 | USE OF PYRIDAZINONE OR PHOSPHINE OXIDE COMPOUNDS TO TREAT OR PREVENT CARDIAC ARRHYTHMIA | MERCK & CO INC (US) | 2007-05-02 | — | — | EP | disclosed |
| EP-1176960-B1 | SYNERGISTIC COMBINATION COMPRISING ROFLUMILAST AND A PDE-3 INHIBITOR | ALTANA PHARMA AG (DE) | 2004-09-29 | — | — | EP | disclosed |
| JP-H01113317-A | ANTIARRHYTHMIC MEDICINE | SMITH KLINE LTD | 1989-05-02 | — | — | JP | disclosed |
| EP-0150937-B1 | DIHYDROPYRIDAZINONES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1988-09-14 | — | — | EP | disclosed |
| EP-0150937-A2 | Dihydropyridazinones | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1985-08-07 | — | — | EP | disclosed |
| WO-1985003076-A1 | DIHYDROPYRIDAZINONES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1985-07-18 | — | — | WO | disclosed |